Septerna, Inc.

SEPNNasdaq· Pharmaceutical Preparations

Price History

Revenue

$46.0M

▲ 4174.5% YoY

Net Income

-$48.9M

▲ 31.9% YoY

EPS

$-1.10

▲ 84.8% YoY

Cash

$120.7M

▼ 49.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.